Pink Sheet
Scrip
Medtech Insight
HBW Insight
Generics Bulletin
In Vivo
In Vivo
Generics Bulletin
HBW Insight
Medtech Insight
Pink Sheet
Scrip
AstraZeneca Stays Hopeful About Ultomiris Despite Initial Conversion Difficulties
Sales of Soliris Successor Stumble
Feb 11 2022
•
By
Ayisha Sharma
AstraZeneca Wants Patients To Switch From Soliris To Ultomiris • Source: Alamy
Keep up with the top pharma business news of the week. On the go.
Scrip brings you a weekly bulletin of top picks.
More from Business
More from Scrip